Nouscom

Nouscom are a biotech company working to develop a series of new, potent immunotherapeutics capable of selectively killing tumor cells.

Nouscom are a well established team that has worked together for many years in previous successful enterprises, including IRBM/Merck and Okairos, and are veterans in the field of oncolytic and genetic vaccines. The company is headquartered in Basel, Switzerland and has operations in Rome, Italy.